Latest News

Enzyme insight could lead to new treatment approach for diabetic patients

Research led by the Centenary Institute has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.

Source link

Related posts

Dole Packaged Foods, LLC invita tutto il mondo ad unirsi agli sforzi della società per garantire l’accesso ad alimenti nutritivi durante l’emergenza COVID-19​


Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS


What’s the Dollar Cost of Caring for a Loved One With Alzheimer’s?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World